Palazestrant

palazestrant · Olema Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Palazestrant, covering 2026-03-13 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer [Phase 3]

See pricing